An adjustable measurement device is described that may include a housing, a power supply, a processor, a communication device, an elastic coupling member, a physiological sensor, and/or a clamp. The housing may be configured to attach to a wearable band that is wearable by a subject. The housing may include a chamber within the housing. The power supply, the processor, the communication device, the elastic coupling member, and or the physiological sensor may be disposed within the chamber. The elastic coupling member may couple the physiological sensor to the housing. A force exerted by the elastic coupling member on the physiological sensor may be in a direction through an opening towards a body part of a subject. As the subject wears the wearable band and the housing is coupled to the wearable band, the physiological sensor may be adjacent to or contact the subject.

The invention provides a system and method for measuring vital signs (e.g. SYS, DIA, SpO2, heart rate, and respiratory rate) and motion (e.g. activity level, posture, degree of motion, and arm height) from a patient. The system features: (i) first and second sensors configured to independently generate time-dependent waveforms indicative of one or more contractile properties of the patient's heart; and (ii) at least three motion-detecting sensors positioned on the forearm, upper arm, and a body location other than the forearm or upper arm of the patient. Each motion-detecting sensor generates at least one time-dependent motion waveform indicative of motion of the location on the patient's body to which it is affixed. A processing component, typically worn on the patient's body and featuring a microprocessor, receives the time-dependent waveforms generated by the different sensors and processes them to determine: (i) a pulse transit time calculated using a time difference between features in two separate time-dependent waveforms, (ii) a blood pressure value calculated from the time difference, and (iii) a motion parameter calculated from at least one motion waveform.

An emergency cardiac and electrocardiogram (ECG) electrode placement device with artificial intelligence is disclosed herein. The emergency cardiac and electrocardiogram (ECG) electrode placement device incorporates electrical conducting materials and elastic material into a pad that is applied to a chest wall of a patient, which places multiple electrodes in the appropriate anatomic locations on the patient to quickly obtain an ECG in a pre-hospital setting. The AI program continuously runs EKGs to continuously monitor a patient.

The concentration of substance in blood is measured non-invasively, with high accuracy and with simple configuration. Laser light 100 generated by a light source 10 is locally irradiated on the body epithelium F of a subject, and the resulting diffused reflected light 200 is detected by a light detector 40. The laser light 100 has a wavelength of 9.26 μm. The laser light 100 is generated by converting and amplifying pulsed excitation light 101 from an excitation light source 11 to a long wavelength. A plate-shaped window 300 that is transparent to mid-infrared light is brought in close contact with the body epithelium F. The glucose concentration in interstitial fluid can be calculated using normalized light intensity calculated from a signal ratio of signals from a monitoring light detector 16 and light detector 40.

The concentration of substance in blood is measured non-invasively, with high accuracy and with simple configuration. Laser light 100 generated by a light source 10 is locally irradiated on the body epithelium F of a subject, and the resulting diffused reflected light 200 is detected by a light detector 40. The laser light 100 has a wavelength of 9.26 μm. The laser light 100 is generated by converting and amplifying pulsed excitation light 101 from an excitation light source 11 to a long wavelength. A plate-shaped window 300 that is transparent to mid-infrared light is brought in close contact with the body epithelium F. The glucose concentration in interstitial fluid can be calculated using normalized light intensity calculated from a signal ratio of signals from a monitoring light detector 16 and light detector 40.

An apparatus is suitable for measuring a photoplethysmogram (PPG). A photoplethysmographic sensor apparatus may include a casing defining a surface, a plurality of optical emitters configured to emit radiation extending from the surface, at least one photo sensor configured to capture radiation emitted by at least a subset of the plurality of optical emitters. At least a first measurement configuration and a second configuration is defined by the plurality of optical emitters and the at least one photo sensor such that the first and the second measurement configuration provide different measurement channels by including at least partially different sets of at least one optical emitter and at least one photo sensor. The first and second measurement configurations define different spatial configurations, each of which is line symmetric with respect to an imaginary line along the surface.

Current glucose meters provide instantaneous results however are invasive and painful thus causing reduced compliance. A non-invasive, portable, wearable device would be ideal for monitoring and recording and provide a distinct advantage to current glucose monitors.

Current glucose meters provide instantaneous results however are invasive and painful thus causing reduced compliance. A non-invasive, portable, wearable device would be ideal for monitoring and recording and provide a distinct advantage to current glucose monitors.

An upper gastrointestinal bleeding monitoring system includes a detection device and a signal processing device to determine bleeding condition of an upper gastrointestinal tract by using relation of time and intensity ratios of RGB three primary colors. The detecting device is placed to the upper gastrointestinal tract of a patient via his/her mouth or nasal passage and then stay the upper gastrointestinal tract for several days for detection of bleeding. The signal processing device may receive and display signal from the detection device to help medical professionals check if bleeding occurs in an upper gastrointestinal tract. Moreover, a procedure of determination of bleeding in an upper gastrointestinal tract with the upper gastrointestinal bleeding monitoring system is described.

A multiple physiological signals sensing chip is provided. The multiple physiological signals sensing chip includes a substrate, a first light-emitting diode, a second light-emitting diode, a sensing array, and a processing unit. The substrate includes a contact surface touched by a finger. The first and second light-emitting diodes respectively emit red light and infrared light to the finger. The sensing array senses the red light or the infrared light reflected or refracted from the finger to obtain first physiological sensing signals according to a first sensing period or senses the red light and the infrared light reflected or refracted from the finger to obtain second physiological sensing signals according to a second sensing period. The first sensing period is shorter than the second sensing period. The processing unit respectively processes the first and second physiological sensing signals to obtain spatial information and energy information corresponding to the finger.